Additionally, ROS in cancer cells activate histone deacetylases (HDACs) and have a dual impact on DNA methyltransferases (DNMT), controlling the expression of oncogenes and tumor suppressor genes, such as N-Ras, K-Ras, c-Myc, and p53. This evidence concerns the gene TP53 and cancer.